2014
DOI: 10.1210/jc.2013-4376
|View full text |Cite
|
Sign up to set email alerts
|

Thyrotropin-Secreting Pituitary Adenomas: Outcome of Pituitary Surgery and Irradiation

Abstract: Surgery remains the first-choice treatment for TSHoma. If surgery is successful, recurrence is rare. When surgery is unsuccessful or contraindicated, SSA and radiotherapy are effective in controlling hyperthyroidism and tumor growth in the majority of patients. The effects of radiotherapy on TSH secretion and tumor mass are greater within the first years after treatment, whereas pituitary deficiencies may occur several years later.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0
11

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 81 publications
(41 citation statements)
references
References 15 publications
0
30
0
11
Order By: Relevance
“…SRLs are used for the treatment of TSH-oma [2, 41, 42]. In our study, presurgical medical treatment with SRLs, but not that with methimazole, was associated with a lower prevalence of VFs.…”
Section: Discussionmentioning
confidence: 48%
See 1 more Smart Citation
“…SRLs are used for the treatment of TSH-oma [2, 41, 42]. In our study, presurgical medical treatment with SRLs, but not that with methimazole, was associated with a lower prevalence of VFs.…”
Section: Discussionmentioning
confidence: 48%
“…Accordingly, vertebral morphometry should be performed both at baseline and during follow-up in patients with TSH-oma. Finally, a relevant number of patients with TSH-oma are not cured by neurosurgery with a consequent relapse of hyperthyroidism [2, 42, 55–57]. Based on the preliminary results of our study, SRL treatment may be proposed in all those patients with active disease in place of methimazole for these apparent favorable effects on skeletal health.…”
Section: Discussionmentioning
confidence: 95%
“…При подтвержденном диагнозе ТТГ-секретирующей опухоли гипофиза предпочтительным методом лечения является удаление тиреотропиномы, позволяющее добиться гормональной ремиссии в 75-84% случаев [4,19,20]. Однако радикальное удаление макротиреотропином достаточно часто сопряжено с техническими трудностями, связанными с фиброзом, инвазией опухоли в кавернозные синусы, внутреннюю сонную артерию или хиазму.…”
Section: Discussionunclassified
“…100 Conventional radiotherapy or radiosurgery are other options when there is incomplete cure with surgery. 101 Antithyroid drugs are avoided given the expected tumor growth if the residual feedback inhibition from thyroid hormones on the tumor is eliminated.…”
Section: Amiodarone-induced Thyroid Dysfunctionmentioning
confidence: 99%